Nurseries Clearview
Positive demographics and a highly fragmented market means the UK nursery sector remains attractive to both corporate nursery chains and financial investors.
Maximising opportunities
We work closely with entrepreneurs and investors at the forefront of the global healthcare revolution. Our in-depth sector knowledge, combined with our technical capability, enables us to help corporates and investors capitalise on the enormous opportunities across the sector as they seek to consolidate and grow their market positions.
The ageing population, technological change, and increased demand for healthcare products and services, all create great opportunities in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. Our job is to help our clients maximise those opportunities.
Our latest transactions
-
Clearwater Advisers
Adviser to BD on the acquisition of infusion assets from Pengyao Pharmaceutical
-
Clearwater Advisers
Adviser to Vivamus on its sale to Altiden, a subsidairy of Ambea
View more -
Clearwater Advisers
Adviser to LDC on the MBO of Ashton Hospital Pharmacy Services supported by Silicon Valley Bank
View more -
Clearwater Advisers
Adviser to the shareholders of 5 Santé on its sale to Korian
View more -
Clearwater Advisers
Adviser to Palatine Private Equity on the sale of Vernacare Group to H.I.G. Capital
View more -
Clearwater Advisers
Advisers to the shareholders of Mathilde Médical Développement group on its sale to Vivalto Santé
View more -
Clearwater Advisers
Adviser to the shareholders of Adonia Medical Group, on its sale to the sk:n Group
View more -
Clearwater Advisers
Advisers to Corpfin Capital and its subsidiary Palex Medical SA on the acquisition of Bemascé Técnica SL
View more -
Clearwater Advisers
Advisers to the shareholders on the sale of Hôpital Privé du Confluent
View more -
Clearwater Advisers
Adviser to Courlancy Santé in its partnership with the Group Saint-Gatien
View more -
Clearwater Advisers
Adviser to Sagesse Retraite Santé on raising capital from Arkéa Capital, Bpifrance and Macif
View more
Luc Bertholat, Partner, Naxicap PartnersClearwater has been very professional in leading the process involving candidates from all over the world.
Our Healthcare Team
The team were quickly able to identify the right partner for us and used their excellent relationship with the buyer to help negotiate a transaction that met our objectives.Dan Smart, CEO, Proclinical
With in-depth knowledge and technical capability, our healthcare team has a great track record of delivering tailored solutions.
See our teamOver 40
deals advised upon
in the last 5 years
€4.6bn
in deal value
over the last 5 years
45%
deals involving PE
in the last 5 years
Insights
-
-
Healthcare Report
The M&A market in healthcare across Europe remains extremely vibrant, with the potential to create pan-European offerings in specific sub-sectors.
Read more -
MedTech Clearview
Solid M&A activity is expected in the coming years in a highly fragmented market, due to drivers such as changes in customer demand, increased complexity in product offerings, and new EU regulations.
Read more
